Alkermes plc (ALKS)
NASDAQ: ALKS · Real-Time Price · USD
30.10
+0.63 (2.14%)
At close: Jan 21, 2025, 4:00 PM
30.12
+0.02 (0.07%)
After-hours: Jan 21, 2025, 4:18 PM EST
Alkermes Employees
Alkermes had 2,100 employees as of December 31, 2023. The number of employees decreased by 180 or -7.89% compared to the previous year.
Employees
2,100
Change (1Y)
-180
Growth (1Y)
-7.89%
Revenue / Employee
$716,724
Profits / Employee
$158,736
Market Cap
4.87B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
ALKS News
- 19 days ago - Alkermes to Present at the 43rd Annual J.P. Morgan Healthcare Conference - PRNewsWire
- 2 months ago - Alkermes to Participate in Upcoming Investor Conferences - PRNewsWire
- 2 months ago - Alkermes: Products Sales, ALKS 2680 Can Still Drive Long-Term Growth - Seeking Alpha
- 2 months ago - Alkermes to Participate in Two Upcoming Investor Conferences - PRNewsWire
- 2 months ago - Alkermes Highlights Presentations From Across Neuroscience Portfolio at Key Fall 2024 Scientific Conferences - PRNewsWire
- 3 months ago - Alkermes plc (ALKS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Alkermes plc Reports Third Quarter 2024 Financial Results - PRNewsWire
- 3 months ago - Alkermes to Report Third Quarter Financial Results on October 24, 2024 - PRNewsWire